[144] AMETEK INC/ SEC Filing

Rhea-AI Filing Summary

AMETEK insider plans to sell 28,390 common shares under Rule 144. The shares are to be sold on the NYSE through Morgan Stanley Smith Barney LLC, with an aggregate market value of $5,727,682.51. AMETEK had 230,203,873 common shares outstanding, and the planned sale date is listed as 12/12/2025.

The securities to be sold were acquired on 06/04/2001 through the exercise of stock options under a registered plan, in two blocks of 16,219 and 12,171 shares paid in cash. Over the past three months, Dave Zapico reported selling 88,000 AMETEK shares on 11/26/2025 for gross proceeds of $17,300,000.00. The signer represents that they are not aware of undisclosed material adverse information about AMETEK’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	28390	5727682.51	230203873	12/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/04/2001	Exercise of options under a registered plan	Issuer			16219	06/04/2001	Cash
Common	06/04/2001	Exercise of options under a registered plan	Issuer			12171	06/04/2001	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dave Zapico 1100 Cassatt Road Berwyn PA 19312	AMEETEK	11/26/2025	88000	17300000.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for AMETEK (AME) disclose?

The filing discloses an insider’s intent to sell 28,390 shares of AMETEK common stock under Rule 144, including details on how and when the shares were acquired and the broker that will handle the sale.

How many AMETEK (AME) shares are planned to be sold and what is their market value?

The notice states that 28,390 common shares are to be sold, with an aggregate market value of $5,727,682.51 based on the price information used in the form.

How does the planned AMETEK (AME) share sale compare with shares outstanding?

At the time referenced, AMETEK had 230,203,873 common shares outstanding. The planned sale of 28,390 shares represents a small portion of this baseline figure.

When and how were the AMETEK (AME) shares being sold under Rule 144 acquired?

The shares were acquired on 06/04/2001 through the exercise of options under a registered plan from the issuer, in two tranches of 16,219 and 12,171 shares paid for in cash.

What recent AMETEK (AME) stock sales by the insider are disclosed?

The filing reports that Dave Zapico, at the listed address in Berwyn, PA, sold 88,000 AMETEK shares on 11/26/2025, generating gross proceeds of $17,300,000.00 over the past three months.

Which broker will handle the AMETEK (AME) shares sale and on which exchange?

The transaction is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, with the securities listed for sale on the NYSE.

What representation does the insider make about AMETEK (AME) in this notice?

By signing the notice, the person for whose account the securities are to be sold represents that they do not know of any material adverse information about AMETEK’s current or prospective operations that has not been publicly disclosed.